Table 5. Intervention effects over secondary outcomes at 12 months according to multilevel regression analysis.
| Outcome measure (at 12 months) | Total | Educore (n = 140) | Usual care (n = 149) | Coefficient Adjusted by cluster and basal level (95% CI) |
| SCORE table score for CVR (n = 264) ‡ | 2.03 (1.67) | 1.98 (1.61) | 2.08 (1.74) | -0.367(-0.905; 0.170) |
| Cholesterol (mg/dl) (n = 281) ‡ | 207.6(33.3) | 206.5 (32.7) | 208.6 (33.9) | -0.870 (-9.460; 7.718) |
| Quality of life (Mini-CHAL) ‡ | ||||
| - Mental status (n = 262) | 3.1 (3.5) | 3.1 (3.4) | 3.0 (4.0) | 0.369 (-0.782;1.521) |
| - Somatic status (n = 268) | 1.4 (2.2) | 1.2 (2.0) | 1.5 (2.3) | -0.372 (-0.882;1.388) |
| Educore (n = 140) | Usual care (n = 149) | OR Adjusted by cluster (95% CI) | ||
| Use of tobacco (Yes) (n = 289) | 20.5% | 19.3% | 21.6% | 0.866 (0.487;-1.537) |
| Compliance with treatment (Yes) (n = 275) | 88.4% | 90.4% | 86.3% | 1.497 (0.708; 3.167) |
‡ Mean (standard deviation). CVR: Cardiovascular risk. Mini-CHAL: quality of life questionnaire validated for use with patients with high blood pressure (Zero [best health level] to 30 [worst health level]) for mental status and 0 to 18 for Somatic status